New Nordic Healthbrands AB (publ) (NNH.ST)
- Previous Close
24.40 - Open
24.90 - Bid 24.40 x --
- Ask 24.80 x --
- Day's Range
24.40 - 24.90 - 52 Week Range
13.20 - 24.90 - Volume
1,694 - Avg. Volume
4,062 - Market Cap (intraday)
153.641M - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
-- - EPS (TTM)
-0.26 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 29, 2022
- 1y Target Est
--
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal remedies, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, and other hair care products; and weight loss products. The company sells its products through pharmacies, department stores, health stores, and travel retailers, as well as through online stores. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
www.newnordic.se77
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NNH.ST
View MorePerformance Overview: NNH.ST
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NNH.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NNH.ST
View MoreValuation Measures
Market Cap
153.64M
Enterprise Value
183.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
1.54
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
26.74
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.29%
Return on Assets (ttm)
1.05%
Return on Equity (ttm)
-1.62%
Revenue (ttm)
563.91M
Net Income Avi to Common (ttm)
-1.66M
Diluted EPS (ttm)
-0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
8.18M
Total Debt/Equity (mrq)
38.60%
Levered Free Cash Flow (ttm)
6.83M